Peachtree Corners, Georgia - Sanguina, Inc., a pioneering medical equipment manufacturing company at the forefront of accessible science and technology for proactive health management, is thrilled to announce the successful completion of its Series A funding round, raising a total of $2.8 million. The investment was led by Veritus Holdings, LLC, a prominent venture capital firm known for backing innovative healthcare solutions.

Co-founded by Erika Tyburski, Sanguina aims to revolutionize the way individuals take control of their health by developing cutting-edge tools with a special focus on anemia screening. The newly acquired funding will propel Sanguina's mission to make health screenings more convenient, accurate, and widely available to empower individuals to act on their health proactively.

Sanguina's Series A funding success comes at a time when advancements in medical technology and the increasing demand for personalized healthcare solutions have never been more critical. With Veritus Holdings, LLC's support and a passionate team behind them, Sanguina is well-positioned to drive innovation, elevate the standard of anemia screening, and pave the way for proactive health management on a global scale.